DE68929273T2 - Stabilisierung von Somatotropinen durch Modifikation von Cystein-Resten durch orts-spezifische Mutagenese oder chemische Derivatisierung - Google Patents

Stabilisierung von Somatotropinen durch Modifikation von Cystein-Resten durch orts-spezifische Mutagenese oder chemische Derivatisierung

Info

Publication number
DE68929273T2
DE68929273T2 DE68929273T DE68929273T DE68929273T2 DE 68929273 T2 DE68929273 T2 DE 68929273T2 DE 68929273 T DE68929273 T DE 68929273T DE 68929273 T DE68929273 T DE 68929273T DE 68929273 T2 DE68929273 T2 DE 68929273T2
Authority
DE
Germany
Prior art keywords
somatotropins
stabilization
site
modification
cysteine residues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68929273T
Other languages
English (en)
Other versions
DE68929273D1 (de
Inventor
Susan Mancini Cady
John Steele Logan
Brian Lee Buckwalter
Gerald W Stockton
Deborah Tardy Chaleff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DE68929273D1 publication Critical patent/DE68929273D1/de
Application granted granted Critical
Publication of DE68929273T2 publication Critical patent/DE68929273T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormones [GH] (Somatotropin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE68929273T 1988-08-24 1989-07-27 Stabilisierung von Somatotropinen durch Modifikation von Cystein-Resten durch orts-spezifische Mutagenese oder chemische Derivatisierung Expired - Fee Related DE68929273T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23606088A 1988-08-24 1988-08-24
US37269989A 1989-07-03 1989-07-03

Publications (2)

Publication Number Publication Date
DE68929273D1 DE68929273D1 (de) 2001-02-01
DE68929273T2 true DE68929273T2 (de) 2001-07-05

Family

ID=26929421

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68929273T Expired - Fee Related DE68929273T2 (de) 1988-08-24 1989-07-27 Stabilisierung von Somatotropinen durch Modifikation von Cystein-Resten durch orts-spezifische Mutagenese oder chemische Derivatisierung

Country Status (18)

Country Link
US (1) US5891840A (de)
EP (1) EP0355460B1 (de)
JP (1) JP2894355B2 (de)
AR (1) AR245138A1 (de)
AT (1) ATE198353T1 (de)
AU (1) AU630105B2 (de)
DE (1) DE68929273T2 (de)
DK (1) DK416589A (de)
ES (1) ES2154627T3 (de)
FI (1) FI104908B (de)
GR (1) GR3035608T3 (de)
HU (1) HU217095B (de)
IE (1) IE892706A1 (de)
IL (1) IL91156A (de)
NO (1) NO893387L (de)
NZ (1) NZ230342A (de)
PT (1) PT91512B (de)
YU (1) YU163289A (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2580303B2 (ja) * 1987-02-19 1997-02-12 ジ・アップジョン・カンパニー 異種蛋白をコ−ド付けするｃＤＮＡ類、発現ベクタ−類および宿主類
US5089473A (en) * 1988-08-29 1992-02-18 Monsanto Company Somatotropin variants and their use
US5079230A (en) * 1988-09-12 1992-01-07 Pitman-Moore, Inc. Stable bioactive somatotropins
US5166322A (en) * 1989-04-21 1992-11-24 Genetics Institute Cysteine added variants of interleukin-3 and chemical modifications thereof
US5951972A (en) * 1990-05-04 1999-09-14 American Cyanamid Company Stabilization of somatotropins and other proteins by modification of cysteine residues
EP0458064B1 (de) * 1990-05-04 1998-02-25 American Cyanamid Company Stabilisierung von Somatotropin durch Modifizierung von Cysteinsresten
US5780599A (en) * 1990-07-13 1998-07-14 Novo Nordisk A/S Growth hormone crystals and a process for production of growth hormone crystals
DK168790D0 (de) * 1990-07-13 1990-07-13 Novo Nordisk As
US6894023B1 (en) 1990-07-13 2005-05-17 Novo Nordisk A/S Growth hormone crystals and a process for production of these GH-crystals
US5849694A (en) * 1990-07-16 1998-12-15 Synenki; Richard M. Stable and bioactive modified porcine somatotropin and pharmaceutical compositions thereof
US5310882A (en) * 1990-11-30 1994-05-10 American Cyanamid Company Somatotropins with alterations in the α-helix 3 region
NZ260103A (en) * 1990-11-30 1996-10-28 Bio Technology General Corp Somatotropin with alterations in the alpha-helix-1 region
GB9100381D0 (en) * 1991-01-09 1991-02-20 Erba Carlo Spa Human bfgf derivatives,their analogs and process for their production
FR2671554A1 (fr) * 1991-01-11 1992-07-17 Clonatec Sa Peptides synthetiques derivant de l'antigene hbc du virus de l'hepatite b, leurs applications a la detection d'une infection par ce virus et a la vaccination contre l'hepatite b.
AU654563B2 (en) * 1991-07-24 1994-11-10 Imperial Chemical Industries Plc Proteins
ZA936811B (en) * 1992-10-28 1995-03-15 Upjohn Co Somatotropin modifications
US7153943B2 (en) 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
US20080076706A1 (en) 1997-07-14 2008-03-27 Bolder Biotechnology, Inc. Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
US6753165B1 (en) 1999-01-14 2004-06-22 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
US7270809B2 (en) 1997-07-14 2007-09-18 Bolder Biotechnology, Inc. Cysteine variants of alpha interferon-2
EP1881005B1 (de) 1997-07-14 2013-04-03 Bolder Biotechnology, Inc. Derivate von G-CSF und damit zusammenhängende Proteine
US7495087B2 (en) 1997-07-14 2009-02-24 Bolder Biotechnology, Inc. Cysteine muteins in the C-D loop of human interleukin-11
US8288126B2 (en) 1999-01-14 2012-10-16 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
EP1284987B1 (de) * 2000-05-16 2007-07-18 Bolder Biotechnology, Inc. Verfahren zur rückfaltung von proteinen mit freien cysteinresten
US6878861B2 (en) 2000-07-21 2005-04-12 Washington State University Research Foundation Acyl coenzyme A thioesterases
US7060442B2 (en) 2000-10-30 2006-06-13 Regents Of The University Of Michigan Modulators on Nod2 signaling
AU2003263552A1 (en) * 2002-09-09 2004-03-29 Nautilus Biotech Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
US7998930B2 (en) 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
WO2007041614A2 (en) 2005-10-03 2007-04-12 Bolder Biotechnology, Inc. Long acting vegf inhibitors and methods of use
US20090269358A1 (en) 2005-10-07 2009-10-29 Shone Clifford C Proteins with Improved Solubility and Methods for Producing and Using Same
WO2008076933A2 (en) 2006-12-14 2008-06-26 Bolder Biotechnology, Inc. Long acting proteins and peptides and methods of making and using the same
CA2733200A1 (en) * 2008-08-06 2010-02-11 Novo Nordisk Health Care Ag Conjugated proteins with prolonged in vivo efficacy
CN102292349B (zh) 2009-01-22 2016-04-13 诺沃—诺迪斯克保健股份有限公司 稳定的生长激素化合物
CN102612376A (zh) 2009-08-06 2012-07-25 诺沃-诺迪斯克保健股份有限公司 具有延长的体内功效的生长激素
CN107674121A (zh) * 2009-12-21 2018-02-09 Ambrx 公司 经过修饰的牛促生长素多肽和其用途
CN106139158A (zh) 2010-01-22 2016-11-23 诺沃—诺迪斯克保健股份有限公司 体内功效延长的生长激素
EP2525833A2 (de) 2010-01-22 2012-11-28 Novo Nordisk Health Care AG Stabile wachstumshormonverbindungen
PL2890394T3 (pl) 2012-08-31 2019-12-31 Glaxosmithkline Biologicals Sa Stabilizowane białka do immunizacji przeciw staphylococcus aureus
US11045523B2 (en) 2013-04-05 2021-06-29 Novo Nordisk Healthcare Ag Formulation of growth hormone albumin-binder conjugate
KR20180003677A (ko) * 2016-06-30 2018-01-10 주식회사 크레아플래닛 인간 성장호르몬 변이 단백질 또는 이의 트랜스페린 융합 단백질을 유효성분으로 포함하는 약학적 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443539A (en) * 1980-02-05 1984-04-17 The Upjohn Company Process for preparing bovine growth hormone
FI82266C (fi) * 1982-10-19 1991-02-11 Cetus Corp Foerfarande foer framstaellning av il-2 -mutein.
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
US4959314A (en) * 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
US4761289A (en) * 1986-10-10 1988-08-02 International Minerals & Chemical Corp. Sustained release implant and method for preparing same
US5079230A (en) * 1988-09-12 1992-01-07 Pitman-Moore, Inc. Stable bioactive somatotropins
AU634517B2 (en) * 1989-01-19 1993-02-25 Pharmacia & Upjohn Company Somatotropin analogs
JP3207416B2 (ja) * 1989-01-31 2001-09-10 ファルマシア・アンド・アップジョン・カンパニー ソマトトロピン・アナログ類
US5849694A (en) * 1990-07-16 1998-12-15 Synenki; Richard M. Stable and bioactive modified porcine somatotropin and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
FI893963A0 (fi) 1989-08-23
IE892706L (en) 1990-02-24
PT91512A (pt) 1990-03-08
HU217095B (hu) 1999-11-29
EP0355460B1 (de) 2000-12-27
ATE198353T1 (de) 2001-01-15
HUT51331A (en) 1990-04-28
ES2154627T3 (es) 2001-04-16
DK416589A (da) 1990-02-25
AU4020289A (en) 1990-03-15
YU163289A (en) 1992-05-28
FI893963A (fi) 1990-02-25
JPH034797A (ja) 1991-01-10
US5891840A (en) 1999-04-06
IL91156A0 (en) 1990-03-19
NO893387L (no) 1990-02-26
DE68929273D1 (de) 2001-02-01
FI104908B (fi) 2000-04-28
NO893387D0 (no) 1989-08-23
EP0355460A3 (de) 1991-04-03
PT91512B (pt) 1995-05-31
NZ230342A (en) 1992-08-26
AR245138A1 (es) 1993-12-30
DK416589D0 (da) 1989-08-23
IE892706A1 (en) 1991-01-16
AU630105B2 (en) 1992-10-22
GR3035608T3 (en) 2001-06-29
IL91156A (en) 1995-05-26
JP2894355B2 (ja) 1999-05-24
EP0355460A2 (de) 1990-02-28

Similar Documents

Publication Publication Date Title
DE68929273T2 (de) Stabilisierung von Somatotropinen durch Modifikation von Cystein-Resten durch orts-spezifische Mutagenese oder chemische Derivatisierung
MX164442B (es) Cloracion mejorada de 6-ester de sacarosa
DE68914178D1 (de) Elektroumstrahlprüfung von elektronischen Komponenten.
DE69128944D1 (de) Stabilisierung von Somatotropin durch Modifizierung von Cysteinsresten
DE68903469T2 (de) Dispergierte teilchen eines gehaerteten silikonmaterials enthaltende fluorkautschukmischung.
AT399591B (de) Analysensiebgerät
DE68928860T2 (de) Belichtungsverfahren
DE68925304D1 (de) Minimale Derivatisierung von Proteinen
DE68925324T2 (de) Photoempfindliches Material und Bildherstellungsverfahren damit
DE68902065D1 (de) Dispergierte teilchen eines gehaerteten silikonmaterials enthaltende fluorkautschukmischung.
DE3780770T2 (de) Therapeutisches gemisch aus einem faenger von freien radikalen oder einem stoffwechsel-hemmer und einem biologisch aktiven protein.
DK604589A (da) Peptider, og analysesaet med indhold af saadanne forbindelser
TR21823A (tr) Temel atese dayanikh cimentolu malzeme ve bunun muerekkip unsurlari
NO172066C (no) Blekeforloeper og bleke/vaskemiddelblanding
DK604689A (da) Peptider, og analysesaet med indhold af saadanne forbindelser
GB8828594D0 (en) Recovery of silver from photographic materials
BR8906376A (pt) Misturas inseticidas condicionadas e processo de tratamento inseticida
PT92587A (pt) Dispositivo e processo de estabilizacao e pesagem
KR880011722U (ko) 세정식 염소가스 중화장치
TR22685A (tr) S-benzil tiolkabamat ihtiva eden herbisidal terkipler ve yabani otlari kontrol usulue
KR890022975U (ko) 오존발생 전극
DK0479670T3 (da) Fremgangsmåde til forbehandling af affald og rester indeholdende natrium- og kaliumioner
KR850007811U (ko) 전자식 타이머를 사용한 가스배출기
KR900012205U (ko) 오존발생 전극의 구조
RO81309A2 (ro) Traductor electronic de pozitie si miscare

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee